Takada, H.; Matsumura, T.; Shimamura, H.; Matsui, M.; Kon, S.; Fukumoto, A.; Kubota, T.; Yoshida, K.; Iwahashi, H.; Takahashi, M.P.
Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic Dystrophy Type 1. J. Clin. Med. 2024, 13, 5252.
https://doi.org/10.3390/jcm13175252
AMA Style
Takada H, Matsumura T, Shimamura H, Matsui M, Kon S, Fukumoto A, Kubota T, Yoshida K, Iwahashi H, Takahashi MP.
Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic Dystrophy Type 1. Journal of Clinical Medicine. 2024; 13(17):5252.
https://doi.org/10.3390/jcm13175252
Chicago/Turabian Style
Takada, Hiroto, Tsuyoshi Matsumura, Haruna Shimamura, Misa Matsui, Seiko Kon, Aono Fukumoto, Tomoya Kubota, Kosuke Yoshida, Hiromi Iwahashi, and Masanori P. Takahashi.
2024. "Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic Dystrophy Type 1" Journal of Clinical Medicine 13, no. 17: 5252.
https://doi.org/10.3390/jcm13175252
APA Style
Takada, H., Matsumura, T., Shimamura, H., Matsui, M., Kon, S., Fukumoto, A., Kubota, T., Yoshida, K., Iwahashi, H., & Takahashi, M. P.
(2024). Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic Dystrophy Type 1. Journal of Clinical Medicine, 13(17), 5252.
https://doi.org/10.3390/jcm13175252
